Bio-Sig-Logo-horiz.jpg
BioSig Launches PURE EP™ Software Version 6 with ACCUVIZ™ Module
22 sept. 2022 09h00 HE | BioSig Technologies, Inc.
Westport, CT, Sept. 22, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), an advanced digital signal processing technology company delivering...
Bio-Sig-Logo-horiz.jpg
BioSig Strengthens Marketing and Sales Teams, Appoints National Account Executives to Scale Commercial Growth
30 août 2022 09h37 HE | BioSig Technologies, Inc.
Westport, CT, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Company increases sales efforts and strategy, adds new National Account Executives to accelerate commercial growth Strengthens marketing team with...
Bio-Sig-Logo-horiz.jpg
BioSig Places Second PURE EP™ System For Evaluation at Cleveland Clinic a Leading Medical Center of Excellence
24 août 2022 09h17 HE | BioSig Technologies, Inc.
Westport, CT, Aug. 24, 2022 (GLOBE NEWSWIRE) -- Leading Medical Center of Excellence adds second PURE EP™ System for evaluation, broadening physician access to the Company’s signal processing...
Bio-Sig-Logo-horiz.jpg
BioSig’s Cardiac Signal Processing Technology To Be Featured at Kansas City Heart Rhythm Symposium 2022
17 août 2022 09h15 HE | BioSig Technologies, Inc.
Westport, CT, Aug. 17, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) ("BioSig" or the "Company"), a medical technology company advancing electrophysiology workflow by delivering...
Bio-Sig-Logo-horiz.jpg
BioSig Sees Positive Momentum from Sales Pipeline Growth
16 août 2022 09h47 HE | BioSig Technologies, Inc.
Westport, CT, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Company sees increase in medical centers entering into 60-day evaluation agreements Existing customers seeing positive results from PURE EP™ System...
Bio-Sig-Logo-horiz.jpg
BioSig Announces Physician-Initiated Research Protocol at The Kansas City Heart Rhythm Institute
21 juil. 2022 10h00 HE | BioSig Technologies, Inc.
Westport, CT, July 21, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) a medical technology company advancing electrophysiology workflow by delivering...
Bio-Sig-Logo-horiz.jpg
BioSig Announces Purchase Agreement with Kansas City Heart Rhythm Institute at Overland Park Regional Medical Center
07 juil. 2022 08h30 HE | BioSig Technologies, Inc.
Westport, CT, July 07, 2022 (GLOBE NEWSWIRE) -- OPRMC marks our first leasing agreement under new program Company also inks national master agreement with one of the largest U.S. healthcare...
Bio-Sig-Logo-horiz.jpg
BioSig Announces Closing of Public Offering of Common Stock
29 juin 2022 17h45 HE | BioSig Technologies, Inc.
Westport, CT, June 29, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) a medical technology company advancing electrophysiology workflow by delivering...
Bio-Sig-Logo-horiz.jpg
BioSig Announces Pricing of Public Offering of Common Stock
24 juin 2022 09h30 HE | BioSig Technologies, Inc.
Westport, CT, June 24, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) a medical technology company advancing electrophysiology workflow by delivering...
Bio-Sig-Logo-horiz.jpg
BioSig Announces Proposed Public Offering of Common Stock
23 juin 2022 16h26 HE | BioSig Technologies, Inc.
Westport, CT, June 23, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal...